| 2021-03-16 | Marker Therapeutics, Inc. MRKR | Chief Development Officer | 571,428 0.9521% | $1.75 | $999,999 | -4.3% | ||
| 2021-03-03 | Sale | AlloVir, Inc. ALVR | director | 15,988 0.0265% | $38.32 | $612,585 | -43.73% | |
| 2021-03-02 | Sale | AlloVir, Inc. ALVR | director | 14,994 0.0243% | $38.11 | $571,396 | -44.77% | |
| 2021-03-01 | Sale | AlloVir, Inc. ALVR | director | 32,854 0.0531% | $38.59 | $1.27M | -45.26% | |
| 2021-02-23 | Sale | AlloVir, Inc. ALVR | director | 8,850 0.0144% | $39.40 | $348,684 | -45.54% | |
| 2021-02-22 | Sale | AlloVir, Inc. ALVR | director | 14,321 0.0237% | $42.57 | $609,614 | -48.86% | |
| 2021-02-19 | Sale | AlloVir, Inc. ALVR | director | 13,233 0.0214% | $41.79 | $553,011 | -48.76% | |
| 2021-02-18 | Sale | AlloVir, Inc. ALVR | director | 8,942 0.0142% | $40.75 | $364,368 | -48.36% | |
| 2021-02-17 | Sale | AlloVir, Inc. ALVR | director | 14,920 0.0235% | $40.34 | $601,860 | -47.9% | |
| 2021-02-16 | Sale | AlloVir, Inc. ALVR | director | 20,800 0.0337% | $41.86 | $870,730 | -48.28% |